A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...

— Novel, third-generation PCSK9 inhibitor designed to help patients more easily achieve lifelong cholesterol goals with robust and sustained LDL-C reductions of 50% or more — — Approved for adults ...

The visiting team looks to bounce back from its crushing 1st Test defeat as the series heads to The Gabba. Kevin Lynch is a London-born, Dublin-based writer and journalist. The author of Steve Jobs: A ...

Chances are, your cholesterol isn’t something you think too much about. When it comes to your health, your thoughts may already be preoccupied with figuring out more ways to get protein, how to get ...

A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered "bad" LDL cholesterol by more than half in a global study ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the United States and globally, accounting for approximately 25% of all deaths in the U.S. alone. Despite advances ...

Matthew Herper covers medical innovation — both its promise and its perils. A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

Notre Dame Fighting Irish kicker Erik Schmidt (18) kicks a field goal during this year’s game against the NC State Wolfpack at Notre Dame Stadium in South Bend. SOUTH BEND — When the Notre Dame ...

Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and legal concerns, The Times found. Round-the-clock fetal monitoring leads to ...